Introduction: Humidifier disinfectants (HDs) study results so far achieved From 2002 through 2020, about 1,600 people were reported to die of fatal injuries associated with the use of humidifier disinfectants (HDs) in South Korea. Several chemical disinfectants used for household humidifiers were later clinically confirmed to cause HD-associated lung injury (HDLI). Polyhexamethylene guanidine phosphate (PHMG-P) is the main ingredient of the HDs associated with lung disease. Epidemiological studies, animal studies, and dose-response analysis demonstrated a strong association between HDs use and lung injuries. The diagnostic criteria for HDLI was defined on the basis of the clinical, pathological, and radiological attributes of the patients [1]. Because of the fatal lung injuries in South Korea, investigations into the adverse health effects of HDs have focused on the lung toxicity of PHMG-P [2]. Therefore, the following toxicologic studies focused on the association between HDs and pulmonary fibrosis. PHMG-P aerosol particles induce pulmonary inflammatory and fibrotic responses [3]. As PHMG-P-induced lung fibrosis is different from that induced by known fibrogenic agents, such as bleomycin, it is important to understand the molecular mechanisms underlying this effect. Guanidine-based disinfectants, PHMG-P, polyhexamethylene biguanide (PHMB), and oligo (2-(2-ethoxy) ethoxyethyl guanidinium chloride (PGH) induce epithelial-mesenchymal transition in A549 alveolar epithelial cells [4]. PHMG-P promotes reactive oxygen species (ROS) generation and consequently increases the expression of DNA damage markers, such as ATM and H2AX phosphorylation [5]. NOTCH1 transcripts significantly increased in lung tissues from HDLI cases compared to unexposed controls (p=0.05), so NOTCH1 may play an important role in the pulmonary fibrosis of HDLI [6]. PHMG-P induced epithelial-mesenchymal transition (EMT) through Akt/NOTCH signaling pathways and ZEB2 played an important role in PHMG-P-induced lung toxicity [7]. Age-period-cohort (APC) analysis using health insurance data showed that many diseases, such as asthma, bronchiec